Big Take13 Apr 2023

What’s Next In the Fight Over the Abortion Pill?

This episode was recorded before a federal appeals court ruling partly granted the Biden administration’s request to put on hold a Texas court decision overturning FDA approval of the abortion pill. The appeals court allowed restrictions that were lifted since 2016 to be reinstated.

For details on the ruling read more here.

The appeals court decision leaves mifepristone on the market while a Justice Department appeal works its way through the courts. It overrules a lower court decision in Texas that sought to stop the sale of the drug completely.

But it did agree with one part of the ruling. It left in place a lower court order that blocked changes that the FDA has made since 2016 that made mifepristone more easily available.

The ruling means that unless the US Supreme Court intervenes by Friday, mifepristone will no longer be approved for use after the seventh week and cannot be dispensed by mail.

Bloomberg journalists Kelsey Butler, Cynthia Koons, and Madlin Mekelburg join this episode to explain what’s at stake if mifepristone becomes unavailable. And Supreme Court correspondent Greg Stohr talks about what’s ahead for these cases, which may well end up in the Justices’ hands.

Listen to The Big Take podcast every weekday and subscribe to our daily newsletter: https://bloom.bg/3F3EJAK

Have questions or comments for Wes and the team? Reach us at bigtake@bloomberg.net.

See omnystudio.com/listener for privacy information.

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(1012)

Could Bond Yields Break the Stock Market?

At over 5%, the 10-year Treasury yield is the highest since 2007. Those soaring yields are raising lots of questions about whether investors should be trimming stocks and buying bonds. But timing such...

28 Sep 17min

Weekend Listen: There's a Mind-Boggling Number of Rich People in America

In 2014, the economists Owen Zidar and Eric Zwick were asked by the US Treasury to conduct a study on the tax burden of private business owners. One of their central findings is that there are about t...

27 Sep 59min

Crafting America’s Favorite Countertops Is Killing Workers

People who fabricate artificial stone are getting sick with a deadly chronic illness—on that, there’s no debate. But whether it’s the individual shops or the material’s manufacturers who should be hel...

25 Sep 21min

This Isn’t Your Grandparents’ UN

At this week’s UN General Assembly meeting in New York, an AI executive delivered dire warnings via video. President Trump threatened to annihilate Iran. China’s Xi Jinping skipped the meeting altoget...

24 Sep 15min

Why Everyone Is Talking About High Diesel Prices

Diesel prices are hitting new highs, and voters aren’t happy. With the midterms approaching, the Trump administration is trying to find ways to curb fuel costs, including a potential US diesel export ...

23 Sep 17min

US-China AI Race to Take Center Stage at Trump-Xi Meeting

As Chinese President Xi Jinping makes his first visit to Washington in over a decade, trade and the AI race will likely dominate talks with Donald Trump. On today’s Big Take Asia podcast, host K. Oanh...

22 Sep 16min

How Much Is the Hormuz Blockade Costing the US?

The Iran War is likely to take center stage when President Trump meets with Gulf leaders on the sidelines of this week's UN General Assembly. Houthi attacks in Saudi Arabia and rising energy prices un...

21 Sep 14min

Big Pharma Needs New Drugs. China Has Them

American pharma giants are increasingly turning to Chinese labs to discover, test and develop cutting-edge drugs. On the Big Take Asia podcast, Bloomberg’s Amber Tong and Robert Langreth join Oanh Ha ...

20 Sep 17min